FDA approves Merck RSV shot for infants, competing with Sanofi and AstraZeneca, reducing hospitalizations
From CNBC: 2025-06-09 15:32:00 The FDA approved Merck’s Enflonsia shot to protect infants from respiratory syncytial virus, competing with Sanofi
